Stay updated on Resmetirom in NASH and Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.

Latest updates to the Resmetirom in NASH and Fibrosis Clinical Trial page
- Check2 days agoChange DetectedAdded related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics to the page.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; this is a minor update that does not affect the page content or its primary functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check16 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check30 days agoChange DetectedGlossary is now shown and the page revision is updated to v3.4.0. A new field 'Last Update Submitted that Met QC Criteria' is displayed, while older terms such as 'No FEAR Act data' and 'MedlinePlus Genetics' are removed and QC wording updated.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page now lists an additional MeSH term 'Non-alcoholic fatty liver disease' and a related topic 'MedlinePlus Genetics', and shows the revision tag v3.3.4.SummaryDifference0.1%

- Check45 days agoChange DetectedRemoved specific related topics from the page: Non-alcoholic fatty liver disease and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Resmetirom in NASH and Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.